Research Topics
| Jeffrey M HolzbeierleinSummaryAffiliation: University of Kansas Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
What effect does androgen suppression therapy have on frequency and timing of fatal myocardial infarctions?Jeffrey M Holzbeierlein
Department of Urology, University of Kansas Hospital, Kansas City, KS 66160, USA
Nat Clin Pract Oncol 5:74-5. 2008
Hsp90: a drug target?Jeffrey M Holzbeierlein
Department of Urology, University of Kansas Hospital, 3901 Rainbow Boulevard, Mail Stop 3016, Kansas, KS, 66160, USA
Curr Oncol Rep 12:95-101. 2010..In addition, to the N-terminal site of Hsp90, the C-terminal site appears to be another target for inhibition of Hsp90. More recently, inhibitors of the C terminus of Hsp90 have been developed and studied in vitro with promising results...
Managing complications of androgen deprivation therapy for prostate cancerJeffrey M Holzbeierlein
Department of Urology, University of Kansas Medical Center, Kansas City, KS 66160, USA
Urol Clin North Am 33:181-90, vi. 2006..This article describes the potential complications of ADT and the recommendations for treatment or prevention of these complications. In addition,we examine the role of nontraditional forms of ADT and the potential benefits they offer...
The role of soy phytoestrogens in prostate cancerJeffrey M Holzbeierlein
Department of Urology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
Curr Opin Urol 15:17-22. 2005..One hypothesis for this reduction in prostate cancer deaths is due to the difference in soy consumption. The purpose of this paper is to review the effects of soy at the molecular level as well as to review the in-vivo effects...
The craft of urologic surgery: modern radical perineal prostatectomyJeffrey M Holzbeierlein
Department of Urology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Mail Stop 3016, Kansas City, KS 66160, USA
Urol Clin North Am 31:629-41, xi-xii. 2004..As discussed in this article, RPP offers several advantages over the retropubic or laparoscopic approach for certain patients...
Complications of androgen deprivation therapy for prostate cancerJeffrey M Holzbeierlein
Department of Urology, University of Kansas Medical Center, Kansas City, 66160, USA
Curr Opin Urol 14:177-83. 2004..Within the last decade, however, there has been a significant increase in its use. Therefore, it is incumbent upon the physician to be familiar with the side effects associated with this treatment...
Complications of androgen deprivation therapy: prevention and treatmentJeffrey M Holzbeierlein
University of Kansas Medical Center, Kansas City, Kansas 66160, USA
Oncology (Williston Park) 18:303-9; discussion 310, 315, 319-21. 2004..This review focuses on the wide range of side effects associated with androgen ablation as well as preventive and treatment strategies...
Complications of androgen-deprivation therapy for prostate cancerJeffrey M Holzbeierlein
Department of Urology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Mail Stop 3016, Kansas City, KS 66160, USA
Clin Prostate Cancer 2:147-52. 2003..Patients and physicians should be well aware of the potential side effects of androgen-deprivation therapy as well as the preventive and treatment strategies for these side effects in order to improve patients quality of life and health...
Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cellsJeffery D Eskew
The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS 66160, USA
BMC Cancer 11:468. 2011....
A phase II clinical trial of neoadjuvant ketoconazole and docetaxel chemotherapy before radical prostatectomy in high risk patientsPaul R Womble
Department of Urology, University of Kansas Hospital, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
J Urol 186:882-7. 2011..Looking for improvement on these outcomes, we conducted a phase II clinical trial examining the combination of ketoconazole and docetaxel in the neoadjuvant setting before radical prostatectomy...
Active surveillance for prostate cancer in a veteran populationEugene K Lee
Department of Urology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
Can J Urol 17:5429-35. 2010..We review our experience with active surveillance in a veteran population...
Evaluation of ureterointestinal anastomosis: Wallace vs BrickerApostolos Evangelidis
Department of Urology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
J Urol 175:1755-8; discussion 1758. 2006..There are no published reports to our knowledge comparing the complication rates of the 2 most frequently used ureterointestinal anastomoses. We compared the Bricker method vs the Wallace method in terms of stricture rate...
Management of the contralateral testicle in patients with unilateral testicular cancerEugene K Lee
University of Kansas Medical Center, Kansas City, KS 66160, USA
World J Urol 27:421-6. 2009..In this review we present the arguments for and against a biopsy of the contralateral testicle, review the techniques of biopsy as well as its complications, and discuss the interventions employed to prevent CIS from progressing...
Cancer immunotherapy: a paradigm shift for prostate cancer treatmentDev Karan
Department of Urology, University of Kansas Medical Center, Kansas City, 3901 Rainbow Boulevard, Kansas City, KS 66106, USA
Nat Rev Urol 9:376-85. 2012....
Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in miceDev Karan
Veterans Affairs Medical Center, Kansas City, MO, USA
Immunotherapy 3:735-46. 2011..We used this adenovirus vector to test the concept that multiantigenic effector T cells could be generated simultaneously following a single immunization...
Prostate imaging modalities that can be used for complementary and alternative medicine clinical studiesReginald W Dusing
Division of Nuclear Medicine, Department of Radiology, Kansas University Medical Center, MS 4032, 3901 Rainbow Boulevard, Kansas City, KS 66160 7234, USA
Urol Clin North Am 38:343-57. 2011..This article presents case studies of PET scanning using carbon 11 acetate and discusses intravenously infused ascorbate, a complementary and alternative medicine therapy for prostate cancer...
Characterization of a novel novobiocin analogue as a putative C-terminal inhibitor of heat shock protein 90 in prostate cancer cellsShawna B Matthews
Department of Urology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
Prostate 70:27-36. 2010..We now report the characterization of the novel novobiocin analogue, F-4, which demonstrates improved cytotoxicity in prostate cancer cell lines compared to the N-terminal inhibitor, 17-AAG...
Adjuvant radiation therapy after radical prostatectomy: when is it indicated?Stephen M Graham
Department of Urology, University of Kansas Medical Center, Kansas City, KS 66160, USA
Curr Urol Rep 10:194-8. 2009..The decision to use ART should be based on the patient's pathological characteristics, clinical status, side effects, and open communication between the patient and provider...
Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selectionJeffrey M Holzbeierlein
Department of Urology, Memorial Sloan-Kettering Cancer Center, 353 E. 68th Street, New York, NY 10021, USA
J Urol 172:878-81. 2004..CONCLUSIONS: In highly selected patients with invasive bladder cancer, partial cystectomy offers acceptable outcomes. Concomitant CIS and presence of metastases to regional lymph nodes predict advanced recurrence...
Finasteride as a chemopreventive agent in prostate cancer: impact of the PCPT on urologic practiceManlio A Goetzl
Department of Urology, University of Kansas Medical Center, Kansas City, KS 66160, USA
Nat Clin Pract Urol 3:422-9. 2006..This review summarizes the PCPT, analyzes its controversial results, and describes future prostate cancer chemoprevention studies...
Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001Jeffrey M Holzbeierlein
Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Urol 169:2122-5. 2003..In patients with metachronous tumors treatment of the contralateral tumor is rarely altered by prior treatment of the initial tumor...
